NCT06648889 2026-01-15Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic LeukemiaGoethe UniversityPhase 2 Recruiting40 enrolled
NCT02112916 2025-12-01Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic LymphomaNational Cancer Institute (NCI)Phase 3 Active not recruiting847 enrolled 19 charts